Search Page

1

Cite

Share

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.

Huang J, Li X, Shi X, Zhu M, Wang J, Huang S, Huang X, Wang H, Li L, Deng H, Zhou Y, Mao J, Long Z, Ma Z, Ye W, Pan J, Xi X, Jin J. Huang J, et al. Among authors: xi x. J Hematol Oncol. 2019 Mar 7;12(1):26. doi: 10.1186/s13045-019-0709-6. J Hematol Oncol. 2019. PMID: 30845955 Free PMC article. Review.

Cite

Share

2

Cite

Share

A Review: The Bioactivities and Pharmacological Applications of Polygonatum sibiricum polysaccharides.

Cui X, Wang S, Cao H, Guo H, Li Y, Xu F, Zheng M, Xi X, Han C. Cui X, et al. Among authors: xi x. Molecules. 2018 May 14;23(5):1170. doi: 10.3390/molecules23051170. Molecules. 2018. PMID: 29757991 Free PMC article. Review.

Cite

Share

3

Cite

Share

Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis.

Yang T, Li Z, Jiang L, Wang Y, Xi X. Yang T, et al. Among authors: xi x. Acta Neurol Scand. 2018 Aug;138(2):104-114. doi: 10.1111/ane.12964. Epub 2018 May 29. Acta Neurol Scand. 2018. PMID: 29845614 Review.

Cite

Share

4

Cite

Share

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.

Wu M, Huang Y, Chen T, Wang W, Yang S, Ye Z, Xi X. Wu M, et al. Among authors: xi x. J Cell Mol Med. 2019 Jan;23(1):29-38. doi: 10.1111/jcmm.13658. Epub 2018 Nov 22. J Cell Mol Med. 2019. PMID: 30565858 Free PMC article.

Cite

Share

5

Cite

Share

Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor.

Chen XJ, Zhang WN, Chen B, Xi WD, Lu Y, Huang JY, Wang YY, Long J, Wu SF, Zhang YX, Wang S, Li SX, Yin T, Lu M, Xi XD, Li JM, Wang KK, Chen Z, Chen SJ. Chen XJ, et al. Among authors: xi xd. Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2220-2225. doi: 10.1073/pnas.1818539116. Epub 2019 Jan 18. Proc Natl Acad Sci U S A. 2019. PMID: 30659143 Free PMC article.

Cite

Share

6

Cite

Share

Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC).

Zhang H, Zhao HY, Xi XX, Liu YJ, Xin M, Mao S, Zhang JJ, Lu AX, Zhang SQ. Zhang H, et al. Among authors: xi xx. Eur J Med Chem. 2020 Mar 1;189:112061. doi: 10.1016/j.ejmech.2020.112061. Epub 2020 Jan 14. Eur J Med Chem. 2020. PMID: 31951960

Cite

Share

7

Cite

Share

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.

Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, Peng J, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C. Zhang L, et al. Among authors: xi x. Lancet. 2016 Oct 15;388(10054):1883-1892. doi: 10.1016/S0140-6736(16)31388-5. Epub 2016 Aug 23. Lancet. 2016. PMID: 27567279 Clinical Trial.

Cite

Share

8

Cite

Share

High-glucose induces retinal pigment epithelium mitochondrial pathways of apoptosis and inhibits mitophagy by regulating ROS/PINK1/Parkin signal pathway.

Zhang Y, Xi X, Mei Y, Zhao X, Zhou L, Ma M, Liu S, Zha X, Yang Y. Zhang Y, et al. Among authors: xi x. Biomed Pharmacother. 2019 Mar;111:1315-1325. doi: 10.1016/j.biopha.2019.01.034. Epub 2019 Jan 15. Biomed Pharmacother. 2019. PMID: 30841445 Free article.

Cite

Share

9

Cite

Share

MicroRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2.

Xi X, Teng M, Zhang L, Xia L, Chen J, Cui Z. Xi X, et al. J Cell Physiol. 2020 Feb;235(2):1330-1338. doi: 10.1002/jcp.29050. Epub 2019 Jul 8. J Cell Physiol. 2020. PMID: 31286521 Retracted.

Cite

Share

10

Cite

Share

Ginsenosides: A Potential Neuroprotective Agent.

Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, Cui X, Cao H, Zhang X, Han C. Zheng M, et al. Among authors: xi x. Biomed Res Int. 2018 May 8;2018:8174345. doi: 10.1155/2018/8174345. eCollection 2018. Biomed Res Int. 2018. PMID: 29854792 Free PMC article. Review.

Cite

Share